Latest Close
$6.00
News
SION
Sionna Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to SION.
1y Change
-$19.89 (-76.83%)
Market Cap
$270,901,952.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
hold
Sionna Therapeutics (SION) Approves 46% Job Cut. Can a New Trial Make its Cash More Productive?
Insider Monkey • Sep 17, 2026
Read articleSION to Cut Workforce by Nearly Half After CF Study Failure, Stock Down
Zacks • Sep 16, 2026
Read articleFDA clears first generic radioligand drug; Sionna turns to layoffs
BioPharma Dive • Sep 15, 2026
Read articleWedbush Raises Price Target on Sionna Therapeutics to $6 From $5, Keeps Neutral Rating
MT Newswires • Sep 15, 2026
Read articleSionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial
GlobeNewswire • Sep 14, 2026
Read articleVertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
Motley Fool • Aug 20, 2026
Read article